RANI GEORGE: Open Payments
NPI 1225562937 · MARRIOTTSVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$484 in 27 payments from 9 companies in 2025. Trend: 2023 $369 · 2024 $522 · 2025 $484
Food & beverage: $484
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $205 |
| Lundbeck LLC | 4 | $76 |
| Janssen Pharmaceuticals, Inc | 2 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Alkermes, Inc. | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: VRAYLAR, REXULTI, INVEGA SUSTENNA, ABILIFY ASIMTUFII, TRINTELLIX, ABILIFY MAINTENA, ARISTADA, FANAPT.
Industry payments across MD — which companies pay providers there.
